/PRNewswire/ AtriAN Medical today announced that it has completed enrollment of a second study using its selective pulsed field ablation (PFA) technology.
/PRNewswire/ Irish medical device company AtriAN Medical today announced that clinical data from it s first-in-human study was presented at this years.